Clinical Trial Detail

NCT ID NCT02960646
Title Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

acute myeloid leukemia

acute lymphoblastic leukemia

myelodysplastic syndrome

non-Hodgkin lymphoma

chronic myelomonocytic leukemia

Hodgkin's lymphoma

chronic myeloid leukemia

lymphoblastic lymphoma

CLL/SLL

multiple myeloma

Therapies

Fludarabine + Melphalan

CD45RA-depleted donor lymphocytes

Cyclophosphamide

Tacrolimus

Rituximab

Age Groups: senior adult

No variant requirements are available.